Nanosphere is advancing health care with innovative diagnostic tools that empower clinicians to make faster, better-informed treatment decisions for their patients. More
Verigene Clinical Microbiology Tests
Nucleic acid-based detection of infectious disease agents in clinical microbiology diagnostics. Gold nanoparticle probe technology: multiplex detection of amplified and non-amplified infectious disease targets.
- Respiratory Virus Plus*
- Gram-Positive Blood Culture*
- Gram-Negative Blood Culture
- C. difficile*
- Enteric Pathogens
- Respiratory Virus XP
- *FDA-Cleared
Verigene Cardiac Tests
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.
- F5/F2/MTHFR*
- Warfarin Metabolism*
- CYP2C19*
- Cardiac Troponin I
- *FDA-Cleared
Verigene Human Genetic Tests
The detection of single nucleotide polymorphisms (SNPs) and similar DNA sequence variations plays an important role in the identification of individual’s who are at risk for having an inherited genetic disorder or are at risk for passing on a disorder to offspring.
- F5/F2/MTHFR*
- Warfarin Metabolism*
- CYP2C19 *
- *FDA-Cleared
Verigene Pharmacogenetic Tests
Pharmacogenetics: genetic variation with differing response to drugs. Gold nanoparticle probe technology enables multitarget detection of single nucleotide polymorphism (SNPs) and similar DNA sequence variations that alter an individual’s metabolism of specific drugs.
- Warfarin Metabolism*
- CYP2C19*
- *FDA-Cleared
Verigene Instruments
- Reader and Processor SP*
- *FDA-cleared



